Observational studyClinical and experimental nephrology2020

Early responsiveness to continuous erythropoietin receptor activator predicts renal prognosis and is determined by a novel antioxidative marker in non-dialysis chronic kidney disease: a prospective, observational, single-center study.

Jun Ino et al.PubMed ↗Publisher ↗

No numbers read from the abstract.